Innovative approaches in unmet clinical needs for maximum health care impact

ROOM 7
WS.III INNOVATIVE APPROACHES IN UNMET CLINICAL NEEDS FOR MAXIMUM HEALTH CARE IMPACT September 21
Co-organized with:

WORKSHOP COMMITTEE Giovanni TOSI, University of Modena and Reggio Emilia Marzia BEDONI, Don Gnocchi Foundation Donatella PAOLINO, University Magna Graecia of Catanzaro
In this day, different actors (academia, industry, regulatory) will discuss and describe the development of innovative and enabling technologies for facing unmet clinical needs, varying from diagnosis to therapeutic aims. In line with Horizon Europe pipelines, pathological focuses will be devoted on cancer, brain related diseases, cardiovascular pathologies. A comprehensive overview of the recent and established innovation in health technologies will be highlighted with a special focus on several aspects strongly impacting on the success of innovation approaches and its application into clinical setting and shown by different sides of view, from design, to materials, characterization, production and scale up, ending to successful stories of yet approved and on market technologies.

September 21
09:00 - 10:30 Innovative approaches in UNMET clinical needs for maximum health care impact - Part 1 WS.III.1 - TT.I.E
Chairs: Marzia BEDONI, Don Gnocchi Foundation, Giovanni TOSI, University of Modena and Reggio Emilia & Donatella PAOLINO, University Magna Graecia of Catanzaro
WS.III.1.1 TT.I.E.1	Jason Thomas DUSKEY - CV University of Modena & Reggio Emilia Targeted Nanomedicines for Cancer Therapy: More than Just Crossing the BBB
WS.III.1.2 TT.I.E.2	Fabio BISCARINI IIT & University of Modena & Reggio Emilia Organic Bioelectronics Multiscale Sensing: state-of—the-art and issues
WS.III.1.3 TT.I.E.3	Francesca RE - CV University of Milano Bicocca Implantable hydrogel design for nanoparticles release useful for glioblastoma treatment
WS.III.1.4 TT.I.E.4	Matteo SANTIN Director of the Centre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, UK Technological and regulatory pathways to accelerate the adoption of nano-diagnostics and nano-medicines in clinics

11:30 - 13:00 Innovative approaches in UNMET clinical needs for maximum health care impact - Part 2 WS.III.2 - TT.II.E
Chairs: Marzia BEDONI, Don Gnocchi Foundation, Giovanni TOSI, University of Modena and Reggio Emilia & Donatella PAOLINO, University Magna Graecia of Catanzaro
WS.III.2.1 TT.II.E.1	Lorena DIÉGUEZ - CV International Iberian Nanotechnology Laboratory, Braga, Portugal Innovative technologies for in vitro diagnosis and monitoring in cancer: towards personalized care
WS.III.2.2 TT.II.E.2	Yuliya SHAKALISAVA Leiden University, Exit 071 (spin off), The Netherlands Innovative microfluidic technology for the analysis of exosomes in therapeutic and diagnostic applications
WS.III.2.3 TT.II.E.3	Marco MONOPOLI - CV Royal College of Surgeons, Ireland Use of nanoparticles for biomolecular diagnostics in chronic disease
WS.III.2.4 TT.II.E.4	Francesca RODÀ - CV LABION Laboratory, Don Gnocchi Foundation Biophotonics-based characterization of liposomes for the treatment of neurological disorders

14:00 - 15:30 Innovative approaches in UNMET clinical needs for maximum health care impact - Part 3 WS.III.3 - TT.III.E
Chairs: Marzia BEDONI, Don Gnocchi Foundation, Giovanni TOSI, University of Modena and Reggio Emilia & Donatella PAOLINO, University Magna Graecia of Catanzaro
WS.III.3.1 TT.III.E.1	Vincenzina MESSINA University of Milano Bicocca DeepRaman: a Deep learning diagnostic pipeline based on Raman spectroscopy
WS.III.3.2 TT.III.E.2	Alessandra BIFFI University of Padova Gene therapy in Rare and Genetic Diseases
WS.III.3.3 TT.III.E.3	Adriele Prina MELLO - CV TRINITY College Dublin, Ireland Non viral RNA/DNA delivery for cancer therapy
WS.III.3.4 TT.III.E.4	Massimo DOMINICI - CV & Giulia GRISENDI University of Modena and Reggio Emilia Innovation in personalized cancer therapy